This bill requires health insurance plans to reimburse providers for all costs associated with administering recommended vaccinations, including both vaccine acquisition costs (based on CDC private sector rates plus 21% for shipping/storage) and full administration costs (like counseling, supplies, and nursing time, using current Medicare rates). It directly affects healthcare providers (such as clinics and doctors' offices) who administer vaccines, ensuring they are compensated for the full cost of delivery. The reimbursement applies specifically to vaccines recommended by the CDC's immunization practices committee, covering standard childhood and adult vaccines like measles, polio, and flu shots. This policy change aims to remove financial barriers for providers to offer routine vaccinations under insurance coverage.
Authorizes certain nursing students to administer certain vaccines pursuant to patient specific orders or non-patient specific orders; authorizes physicians and certified nurse practitioners to prescribe and order a patient specific order or non-patient specific order to a nursing student to administer certain vaccines.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
This bill (S 8756) modifies the implementation timeline for a law allowing close friends to arrange body donations for medical purposes after a person's death. It changes the effective date so that the health commissioner can immediately begin implementing the law - rather than waiting 180 days - upon the bill's passage. This adjustment primarily affects individuals who wish to donate a deceased person's body for medical education or research, ensuring faster administrative readiness. The bill is procedural in nature, focusing solely on implementation timing, not the eligibility for body donations.
This bill changes the language in New York's Public Health Law by replacing the term "addict" with "person with substance use disorder" in sections governing medical treatment. It specifically affects healthcare practitioners who prescribe controlled substances for maintenance or detoxification treatment, ensuring they reference patients as "person with substance use disorder" instead of "addict" in legal documents. The key mechanism is a simple terminology update within existing prescribing provisions, aiming to use more clinical and less stigmatizing language. This change aligns with broader efforts to reduce stigma in healthcare communication.
Requires anti-bias training for every medical student, medical resident and physician assistant student in the state; requires the department of health to make an annual report on the implementation and effectiveness of such training.
Relates to requirements for medical professionals and health care facilities that provide medication to patients for medical aid in dying; extends the initial effectiveness of certain provisions relating thereto.
This bill establishes New York's "Medical Aid in Dying Act," allowing terminally ill adults (18+) with decision-making capacity to request and self-administer medication to end their life. To qualify, a patient must have a terminal illness confirmed by two physicians (the attending physician and a consulting physician) and make an informed decision after being fully informed of alternatives, risks, and outcomes. The process requires an oral request, a written request signed by the patient and witnessed by two non-conflicted adults (not relatives or beneficiaries), and includes the right to rescind the request at any time. The bill also mandates documentation, safe disposal of unused medication, and state reporting.
Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.